Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

TOOsonix receives MDR CE Mark for its new oncology and dermatology device

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1
PR Newswire associated2
PR Newswire associated3

Tags

TOOsonix

More Like This

PR Newswire associated0

TOOsonix Partners with MikronMed to Introduce Innovative Dermatological Therapy in the Nordic Region

PR Newswire associated0

TOOsonix Partners with Consultronix to Introduce its Innovative Dermatological Therapy in Poland

PR Newswire associated0

THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)

HistoSonics Non-Invasive Edison Histotripsy System

HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation

HistoSonics Edison Histotripsy System (Photo: Business Wire)

FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System

Business Wire logo

HistoSonics Awarded Key Position in UK’s Novel Innovation Program

HistoSonics Edison Histotripsy System (Photo: Business Wire)

World’s First Patients Treated With Novel Edison® Histotripsy System

PR Newswire associated0

DOSIsoft PLANET® Onco Dose receives CE MDR Mark and new FDA 510(k) clearance

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us